Showing results (91-100 of 241) with videos related to

Sort By:
Pageof 25
Investigational New Drugs|April 26, 2014
Evaluation of a novel blood pressure scoring method and its association with clinical response in cancer patients treated with anti-vascular endothelial growth factor therapyMehmet Asim Bilen, Jean-Bernard Durand, Lacey McQuinn, et al.
Journal for Immunotherapy of Cancer|December 20, 2017
Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trialsRoman Groisberg, David S Hong, Amini Behrang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube CancerSiqing Fu, Bradley R Corr, Kerry Culm-Merdek, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Phase I clinical trial of bendamustine and bevacizumab for patients with advanced cancerApostolia M Tsimberidou, Alexandra M Adamopoulos, Yang Ye, et al.
The Oncologist|June 16, 2020
Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic FindingsMansoor Saleh, Philippe A Cassier, Lauriane Eberst, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
Molecular Cancer Therapeutics|August 24, 2012
Mechanistic basis for overcoming platinum resistance using copper chelating agentsZheng D Liang, Yan Long, Wen-Bin Tsai, et al.
Cancer Research|October 16, 2012
PIK3CA mutation H1047R is associated with response to PI3K/AKT/mTOR signaling pathway inhibitors in early-phase clinical trialsFilip Janku, Jennifer J Wheler, Aung Naing, et al.
Oncotarget|February 26, 2013
Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancerGerald S Falchook, Aung Naing, David S Hong, et al.
Investigational New Drugs|May 21, 2015
Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liverRabih Said, Razelle Kurzrock, Aung Naing, et al.
Pageof 25